Cytosorbents Corporation (CTSO)
USD 0.86
(5.91%)
USD 0.86
(5.91%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 18.31 Million USD | 0.34% |
| 2022 | 18.25 Million USD | 32.04% |
| 2021 | 13.82 Million USD | 1243.25% |
| 2020 | 1.02 Million USD | -93.62% |
| 2019 | 16.12 Million USD | 62.19% |
| 2018 | 9.94 Million USD | -0.51% |
| 2017 | 9.99 Million USD | 103.44% |
| 2016 | 4.91 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 1.64 Million USD | 77.53% |
| 2012 | 926.22 Thousand USD | 62.33% |
| 2011 | 570.57 Thousand USD | -47.04% |
| 2010 | 1.07 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 50 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 60 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 17.61 Million USD | -3.83% |
| 2024 Q2 | 26.76 Million USD | 51.98% |
| 2023 FY | 18.31 Million USD | 0.34% |
| 2023 Q4 | 18.31 Million USD | 1.51% |
| 2023 Q3 | 18.04 Million USD | -0.4% |
| 2023 Q2 | 18.11 Million USD | -0.39% |
| 2023 Q1 | 18.18 Million USD | -0.37% |
| 2022 Q4 | 18.25 Million USD | 36.34% |
| 2022 Q1 | 13.65 Million USD | -1.18% |
| 2022 FY | 18.25 Million USD | 32.04% |
| 2022 Q2 | 13.5 Million USD | -1.1% |
| 2022 Q3 | 13.38 Million USD | -0.91% |
| 2021 Q1 | 923.96 Thousand USD | -10.22% |
| 2021 FY | 13.82 Million USD | 1243.25% |
| 2021 Q2 | 13.26 Million USD | 1335.51% |
| 2021 Q3 | 13.65 Million USD | 2.93% |
| 2021 Q4 | 13.82 Million USD | 1.25% |
| 2020 Q3 | 16.29 Million USD | -0.39% |
| 2020 FY | 1.02 Million USD | -93.62% |
| 2020 Q1 | 16.05 Million USD | -0.4% |
| 2020 Q2 | 16.35 Million USD | 1.86% |
| 2020 Q4 | 1.02 Million USD | -93.68% |
| 2019 Q4 | 16.12 Million USD | -0.38% |
| 2019 Q3 | 16.18 Million USD | 43.82% |
| 2019 Q2 | 11.25 Million USD | -0.62% |
| 2019 Q1 | 11.32 Million USD | 13.91% |
| 2019 FY | 16.12 Million USD | 62.19% |
| 2018 Q1 | 9.86 Million USD | -1.22% |
| 2018 Q3 | 9.91 Million USD | 0.24% |
| 2018 Q4 | 9.94 Million USD | 0.24% |
| 2018 FY | 9.94 Million USD | -0.51% |
| 2018 Q2 | 9.89 Million USD | 0.24% |
| 2017 Q4 | 9.99 Million USD | 0.26% |
| 2017 Q2 | 9.94 Million USD | 101.76% |
| 2017 FY | 9.99 Million USD | 103.44% |
| 2017 Q1 | 4.92 Million USD | 0.31% |
| 2017 Q3 | 9.96 Million USD | 0.26% |
| 2016 Q4 | 4.91 Million USD | 0.31% |
| 2016 FY | 4.91 Million USD | 0.0% |
| 2016 Q3 | 4.89 Million USD | 0.31% |
| 2016 Q2 | 4.88 Million USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 Q3 | - USD | -100.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | 1.72 Million USD | 5.03% |
| 2014 Q2 | 709.33 Thousand USD | -58.93% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 1.64 Million USD | 77.53% |
| 2013 Q2 | 912.1 Thousand USD | 0.0% |
| 2013 Q3 | 1.56 Million USD | 71.21% |
| 2013 Q4 | 1.64 Million USD | 5.3% |
| 2012 FY | 926.22 Thousand USD | 62.33% |
| 2012 Q1 | 1.14 Million USD | 101.08% |
| 2012 Q4 | 926.22 Thousand USD | -4.84% |
| 2012 Q3 | 973.37 Thousand USD | -17.88% |
| 2012 Q2 | 1.18 Million USD | 3.31% |
| 2011 Q4 | 570.57 Thousand USD | 23.28% |
| 2011 Q1 | 493.84 Thousand USD | -54.16% |
| 2011 Q2 | 526.55 Thousand USD | 6.62% |
| 2011 Q3 | 462.83 Thousand USD | -12.1% |
| 2011 FY | 570.57 Thousand USD | -47.04% |
| 2010 Q3 | 871.68 Thousand USD | 405.33% |
| 2010 FY | 1.07 Million USD | 0.0% |
| 2010 Q4 | 1.07 Million USD | 23.6% |
| 2010 Q1 | 172.5 Thousand USD | 0.0% |
| 2010 Q2 | 172.5 Thousand USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q2 | 50 Thousand USD | 0.0% |
| 2009 Q3 | - USD | -100.0% |
| 2009 Q1 | 50 Thousand USD | 0.0% |
| 2008 Q1 | 100 Thousand USD | 0.0% |
| 2008 Q4 | 50 Thousand USD | 0.0% |
| 2008 Q3 | 50 Thousand USD | 0.0% |
| 2008 Q2 | 50 Thousand USD | -50.0% |
| 2008 FY | 50 Thousand USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q3 | 1 Million USD | 0.0% |
| 2006 Q2 | 1 Million USD | 1372.47% |
| 2006 FY | - USD | -100.0% |
| 2006 Q1 | 67.91 Thousand USD | 2.69% |
| 2005 Q4 | 66.13 Thousand USD | 561.37% |
| 2005 Q3 | 10 Thousand USD | -83.33% |
| 2005 Q1 | 60 Thousand USD | 500.0% |
| 2005 FY | 60 Thousand USD | 0.0% |
| 2005 Q2 | 60 Thousand USD | 0.0% |
| 2004 Q4 | 10 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 96.619% |
| Nemaura Medical Inc. | 20.03 Million USD | 8.572% |
| NeuroPace, Inc. | 72.39 Million USD | 74.704% |
| LENSAR, Inc. | 2.3 Million USD | -693.12% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -149.294% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -1048.16% |
| Apyx Medical Corporation | 38.5 Million USD | 52.435% |
| Cutera, Inc. | 431.91 Million USD | 95.76% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -17.144% |
| BioSig Technologies, Inc. | 452 Thousand USD | -3951.582% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 53.307% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 98.911% |
| Axonics, Inc. | 27.61 Million USD | 33.689% |
| IRIDEX Corporation | 2.74 Million USD | -566.903% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 76.879% |
| TELA Bio, Inc. | 42.78 Million USD | 57.192% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -4862.914% |
| RxSight, Inc. | 3.01 Million USD | -508.006% |
| Align Technology, Inc. | 96.96 Million USD | 81.114% |
| INVO Bioscience, Inc. | 8.68 Million USD | -110.894% |
| electroCore, Inc. | 626 Thousand USD | -2825.424% |
| Telesis Bio, Inc. | 34.38 Million USD | 46.733% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -78.296% |
| Quipt Home Medical Corp. | 98.94 Million USD | 81.491% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 36.932% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -679.947% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -20.047% |
| Dynatronics Corporation | 6.68 Million USD | -173.823% |
| Modular Medical, Inc. | 1.19 Million USD | -1438.92% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -6889.753% |
| Talis Biomedical Corporation | 19.66 Million USD | 6.889% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -1241.584% |
| InMode Ltd. | 9.01 Million USD | -103.096% |
| Envoy Medical, Inc. | 404 Thousand USD | -4432.958% |
| Bruker Corporation | 1.37 Billion USD | 98.673% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -32028.337% |
| DexCom, Inc. | 2.59 Billion USD | 99.294% |
| Nexalin Technology, Inc. | 4463.00 USD | -410232.781% |
| PAVmed Inc | 48.72 Million USD | 62.415% |
| Viveve Medical, Inc. | 5.34 Million USD | -242.366% |
| Cerus Corporation | 95.99 Million USD | 80.924% |
| Movano Inc. | 252 Thousand USD | -7167.124% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 44.797% |
| Nexalin Technology, Inc. | 4463.00 USD | -410232.781% |
| IceCure Medical Ltd | 599 Thousand USD | -2957.287% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 95.594% |
| enVVeno Medical Corporation | 1.4 Million USD | -1206.216% |
| 908 Devices Inc. | 5.94 Million USD | -208.043% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -31.362% |
| Orthofix Medical Inc. | 134.19 Million USD | 86.354% |
| Surmodics, Inc. | 29.4 Million USD | 37.721% |
| Nuwellis, Inc. | 981 Thousand USD | -1766.784% |
| Outset Medical, Inc. | 136.18 Million USD | 86.553% |
| Venus Concept Inc. | 79.69 Million USD | 77.022% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 85.894% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 73.951% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -118.118% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -1847.553% |
| Inogen, Inc. | 21.92 Million USD | 16.466% |
| IRadimed Corporation | 2.04 Million USD | -796.366% |
| MaxCyte, Inc. | 18.74 Million USD | 2.293% |
| Pulmonx Corporation | 41.42 Million USD | 55.791% |
| PAVmed Inc. | 48.72 Million USD | 62.415% |
| iCAD, Inc. | 461 Thousand USD | -3872.484% |
| OrthoPediatrics Corp. | 23.76 Million USD | 22.924% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -817.263% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -3622.253% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -9831.21% |
| SI-BONE, Inc. | 38.99 Million USD | 53.034% |
| Semler Scientific, Inc. | 70 Thousand USD | -26061.646% |
| Beyond Air, Inc. | 17.83 Million USD | -2.669% |
| FONAR Corporation | 41.67 Million USD | 56.058% |
| AxoGen, Inc. | 69.29 Million USD | 73.571% |
| Biotricity, Inc. | 23.87 Million USD | 23.308% |
| ZimVie Inc. | 521.92 Million USD | 96.491% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 63.646% |
| Inari Medical, Inc. | 32.04 Million USD | 42.855% |
| UFP Technologies, Inc. | 46.03 Million USD | 60.221% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -817.263% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -496.313% |
| Sight Sciences, Inc. | 35.41 Million USD | 48.288% |
| Insulet Corporation | 1.44 Billion USD | 98.736% |
| Profound Medical Corp. | 7.9 Million USD | -131.801% |
| Bioventus Inc. | 409.47 Million USD | 95.528% |
| InspireMD, Inc. | 1.59 Million USD | -1048.16% |
| BrainsWay Ltd. | 471 Thousand USD | -3788.143% |
| BIOLASE, Inc. | 17.91 Million USD | -2.251% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -1667.102% |
| Tenon Medical, Inc. | 1.17 Million USD | -1461.224% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1727.66% |
| CVRx, Inc. | 30.61 Million USD | 40.179% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.202% |
| Sintx Technologies, Inc. | 4.24 Million USD | -331.405% |
| Acutus Medical, Inc. | 38.47 Million USD | 52.407% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -817.952% |
| NanoVibronix, Inc. | 5000.00 USD | -366163.04% |
| Quanterix Corporation | 41.46 Million USD | 55.834% |
| LivaNova PLC | 640.4 Million USD | 97.14% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -512.364% |
| Varex Imaging Corporation | 469.5 Million USD | 96.099% |
| Vivani Medical, Inc. | 20.69 Million USD | 11.514% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -679.947% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -2238.844% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 98.039% |
| TransMedics Group, Inc. | 515.94 Million USD | 96.451% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -862.331% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -7502.73% |
| Spectral AI, Inc. | 1.28 Million USD | -1320.726% |
| Hyperfine, Inc. | 185 Thousand USD | -9799.001% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 90.473% |
| Biomerica, Inc. | 785 Thousand USD | -2232.886% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -3974.27% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -4848.096% |
| Silk Road Medical, Inc | 84.63 Million USD | 78.362% |